VNRX
Volitionrx Ltd
$1.16
-0.02 (-1.69%)
At close · Jul 16
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The possibility that we may not be able to continue to operate, as indicated by the “going concern” opinion from our auditors”View the 10-Q filed May 14, 2026
Market Cap
$9.16M
Shares
8,330,270
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.73M
+40%
FY2025
Net Income
-$23.36M
+13.4%
FY2025
Operating Margin
-1258.47%
+932.4pp
FY2025
Diluted EPS
-$6.20
+38%
FY2024
Operating Cash Flow
-$19.68M
+24%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $2.47M | $1.73M | $1.23M | $775.3K | $306.39K | $90.04K | $13.43K | $17.1K | — | — | — | — | $14.79K | $54.97K | $54.97K | $0 | |
| $10.33M | $10.08M | $14.41M | $19.55M | $15.33M | $13.02M | $14.53M | $10.36M | $10.91M | $8.03M | $7.9M | $6.1M | $4.04M | $2.5M | $2.77M | $1.52M | |
| $3.86M | $3.92M | $5.36M | $6.84M | $6.58M | $3.72M | $1.07M | $965.71K | $1.17M | $836.47K | $347.71K | — | — | — | — | — | |
| $9.85M | $9.46M | $8.49M | $10.37M | $10.18M | $11.68M | $5.65M | $4.73M | $5.82M | $5.83M | $4.18M | $669.02K | $299.05K | $434.01K | $448.04K | $247.41K | |
| — | $24.01K | $0 | $84.91K | $75.56K | $91.65K | $88.63K | $87.29K | $91.91K | $87.99K | $86.46K | $85.9K | $95.04K | $114.88K | $112.06K | $107.64K | |
| — | $983.71K | $1.11M | $1.15M | $936.08K | $945.37K | $716.18K | $676.82K | $636.38K | $528.17K | $309.41K | $236.34K | $142.13K | $146.4K | $135.74K | $118.62K | |
| $24.03M | $23.47M | $28.26M | $36.76M | $32.09M | $28.42M | $21.26M | $16.06M | $17.9M | $14.7M | $12.43M | $10.01M | $5.95M | $4.58M | $4.14M | $2.61M | |
| -$21.57M | -$21.74M | -$27.02M | -$35.99M | -$31.78M | -$28.33M | -$21.25M | -$16.04M | -$17.9M | -$14.7M | -$12.43M | -$10.01M | -$5.95M | -$4.58M | -$4.08M | -$2.61M | |
| — | -1258.47% | -2190.9% | -4641.76% | -10372.36% | -31468.96% | -158176.25% | -93840.22% | — | — | — | — | -40258.37% | -8324.68% | -7428.05% | — | |
| — | -$20.75M | -$25.91M | -$34.84M | -$30.84M | -$27.39M | -$20.53M | -$15.37M | -$17.26M | -$14.17M | -$12.12M | -$9.77M | -$5.81M | -$4.43M | -$3.95M | -$2.49M | |
| — | — | — | — | — | $155.8K | $129.8K | $126.57K | -$110.92K | $73.13K | $20.38K | — | — | — | — | — | |
| -$3.16M | -$1.76M | -$233.02K | $310.62K | $1.18M | $1.34M | $848.52K | -$56.13K | -$110.92K | — | — | -$15.68K | $14.79K | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | -$4604 | — | — | — | — | |
| -$24.57M | -$23.36M | -$26.97M | -$35.68M | -$30.6M | -$26.99M | -$20.4M | -$16.1M | -$18.01M | -$14.77M | -$11.91M | -$9.53M | -$8.21M | -$3.71M | -$4.08M | -$2.61M | |
| — | -1352.16% | -2186.27% | -4601.7% | -9986.71% | -29976.99% | -151859.55% | -94168.55% | — | — | — | — | -55553.12% | -6749.91% | -7428.05% | — | |
| — | — | -$290.15K | -$358K | $329.68K | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | -$26.97M | -$35.32M | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$25.02M | -$24.18M | -$27.12M | -$35.66M | -$30.52M | — | — | — | -$17.66M | -$14.71M | -$12.01M | -$9.51M | -$8.26M | -$3.74M | -$4.12M | -$2.57M | |
| USD/shares | — | — | -$6.20 | -$10.00 | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | — | — | — | — | 2.63M | 2.26M | 1.96M | 1.57M | 1.32M | 1.15M | 886.59K | 671.76K | 541.62K | 468K | — |
| shares | — | 5.34M | 4.33M | 3.56M | — | 2.63M | 2.26M | 1.96M | 1.57M | 1.32M | 1.15M | 886.59K | 671.76K | 541.62K | 468K | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2024: $31.77K in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Devices median 2.33×
EV/EBIT
—
Medical Devices median 21.55×
P/E (TTM)
—
Medical Devices median 28.30×